###begin article-title 0
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
Sporadic ALS is not associated with VAPB gene mutations in Southern Italy
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sod1</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sod1 </italic>
###xml 474 482 <span type="species:ncbi:9606">patients</span>
###xml 518 526 <span type="species:ncbi:9606">patients</span>
Mutations in the Cu/Zn superoxide dismutase (Sod1) gene have been reported to cause adult-onset autosomal dominant Amyotrophic Lateral Sclerosis (FALS). In sporadic cases (SALS) de novo mutations in the Sod1 gene have occasionally been observed. The recent finding of a mutation in the VAMP/synaptobrevin-associated membrane protein B (VAPB) gene as the cause of amyotrophic lateral sclerosis (ALS8), prompted us to investigate the entire coding region of this gene in SALS patients. One hundred twenty-five unrelated patients with adult-onset ALS and 150 healthy sex-age-matched subjects with the same genetic background were analyzed.
###end p 2
###begin p 3
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
###xml 638 643 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 576 584 <span type="species:ncbi:9606">patients</span>
Genetic analysis for all exons of the VAPB gene by DHPLC revealed 5 variant profiles in 83 out of 125 SALS patients. Direct sequencing of these PCR products revealed 3 nucleotide substitutions. Two of these were found within intron 3 of the gene, harbouring 4 variant DHPLC profiles. The third nucleotide variation (Asp130Glu) was the only substitution present in the coding region of the VAPB gene, and it occurred within exon 4. It was found in three patients out of 125. The frequency of the detected exon variation in the VAPB gene was not significantly different between patients and controls. In conclusion, our study suggests that VAPB mutations are not a common cause of adult-onset SALS.
###end p 3
###begin title 4
Findings
###end title 4
###begin p 5
###xml 532 536 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sod1</italic>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 541 542 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SETX</italic>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 741 747 741 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alsin </italic>
###xml 769 770 769 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 826 831 826 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sod1 </italic>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 883 889 883 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alsin </italic>
###xml 914 915 914 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
Amyotrophic Lateral Sclerosis (ALS) is a progressive lethal disorder of motor neurons of the spinal cord and brain. More than 90% of ALS patients are sporadic (SALS), not showing any familial trait. Approximately 10% of cases are familial (FALS), and within these lie several distinct forms of the disease. The most common form of FALS is autosomal dominant for which to date 2 genes have been identified: ALS1, with adult-onset caused by mutations in the gene encoding the cytosolic antioxidant enzyme Cu, Zn-superoxide dismutase (Sod1) [1,2]; and ALS4, a rare juvenile-onset disorder, associated with mutations of the senataxin gene (SETX) [3]. An autosomal recessive, juvenile-onset form (ALS2), has been associated with mutations of the Alsin gene located at 2q33 [4]. To date over 100 different missense mutations in the Sod1 gene [5] and up to eight described mutations in the Alsin gene have been reported [6].
###end p 5
###begin p 6
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sod1 </italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
By contrast, sporadic ALS is believed to be a multi-factorial disease in which modifying genes and environmental agents affect its clinical manifestation, but few associated genes have so far been identified [7-13]. De novo mutations in the Sod1 gene have only occasionally been observed in sporadic cases of ALS suggesting that mutations in this gene are a rare cause of non familial forms of ALS [14,15].
###end p 6
###begin p 7
###xml 15 31 15 31 <underline xmlns:xlink="http://www.w3.org/1999/xlink">Nishimura et al.</underline>
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB</italic>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
The finding by Nishimura et al.[16] of a missense mutation in the VAMP/synaptobrevin-associated membrane protein B (VAPB) gene in autosomal dominant motoneuron diseases (ALS8), prompted us to investigate the entire coding region of this gene in 125 SALS patients.
###end p 7
###begin p 8
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sod1 </italic>
###xml 461 466 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
###xml 385 393 <span type="species:ncbi:9606">patients</span>
Following informed consent, blood was taken from 125 unrelated Caucasian patients from Southern Italy, who fulfilled the El Escorial criteria [17] for ALS. Samples were also taken from 150 controls, matched for age, sex and geographic region. Clinical information is provided in Table 1. Lymphocyte DNA was extracted from blood samples using standard procedure. Sod1 mutation-negative patients were screened using primer flanking the intron-exon regions of the VAPB gene. The PCR products were analyzed by Denaturing High Performance Liquid Chromatography (DHPLC) on a WAVE Nucleic Acid Fragment Analysis System (Transgenomic Inc., Mountain View, CA). Representative samples with abnormal profile in DHPLC were sequenced by the ABI Prism BigDye Terminator cycle sequencing ready reaction kit (Perkin Elmer- Applied Biosystems Inc., Foster City, CA).
###end p 8
###begin p 9
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
DHPLC analysis of the VAPB gene [GenBank accession no. ] detected five variant profiles in 83 out of 125 SALS patients. Direct sequencing of PCR products revealed 3 nucleotide substitutions. Two nucleotide substitutions, g.134585C>T and g.134688A>G were found within intron 3 of the gene, harbouring 4 variant DHPLC profiles, because of their combination in homozygous or heterozygous states. These polymorphisms were already present in the SNP database as rs 2234487 and rs 2234488, respectively [18]. The frequencies in our SALS patients and in control population were 65% vs 64% for the rs 2234487 and 42% vs 45% for the rs 2234488, respectively.
###end p 9
###begin p 10
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
The third nucleotide substitution was the only substitution present in the coding region of the VAPB gene and it occurred within exon 4 at nucleotide g.138864T>G (Asp130Glu).
###end p 10
###begin p 11
###xml 238 246 <span type="species:ncbi:9606">patients</span>
The Asp130Glu variation is located between MSP and Coiled-coil domains, and involves an aminoacid residue of aspartic acid not conserved among different species. We identified this variation in heterozygous state in three out of 125 SALS patients (2.0%) and in three of 150 (2.4%) sex-age-matched healthy subjects from the same geographical area, suggesting that this aminoacidic substitution is not causative of the disease.
###end p 11
###begin p 12
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VAPB </italic>
The data presented herein suggest that VAPB mutations are not a common cause of adult-onset SALS in Italian population. Further, the novel nucleotide variation identified in exon 4 of VAPB gene represents a polymorphism, probably linked to a restrict geographic area.
###end p 12
###begin title 13
Authors' contributions
###end title 13
###begin p 14
###xml 281 288 <span type="species:ncbi:9606">patient</span>
FLC conceived of the molecular study and participated its design and coordination and wrote the manuscript. RM and MM participated in the design of study and helped to draft the manuscript. AT, GT, MRM, VL, ILS, GM, PV, provided the samples and performed clinical diagnosis of the patient group from Naples, Palermo, Bari, Messina and Catanzaro, respectively. TS and CU carried out the molecular genetic study and performed DHPLC analysis. AP, AM, and ALG participated in carrying out the sequencing. AQ conceived of the study and participated its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 14
###begin p 15
Clinical information of the studied populations
###end p 15
###begin p 16
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a Mean age of onset (with lowest/highest and Standard Deviation values in parentheses);
###end p 16
###begin p 17
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
b SALS: Sporadic Amyotrophic Lateral Sclerosis
###end p 17
###begin article-title 18
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
###end article-title 18
###begin article-title 19
Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis
###end article-title 19
###begin article-title 20
Chance, DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)
###end article-title 20
###begin article-title 21
The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis
###end article-title 21
###begin article-title 22
Website title
###end article-title 22
###begin article-title 23
Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis
###end article-title 23
###begin article-title 24
The genetics of motor neuron diseases
###end article-title 24
###begin article-title 25
Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS
###end article-title 25
###begin article-title 26
SOD1 mutations associated with accumulation of neurofilaments in amyotrophic lateral sclerosis
###end article-title 26
###begin article-title 27
###xml 55 59 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 64 70 <span type="species:ncbi:9606">humans</span>
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
###end article-title 27
###begin article-title 28
###xml 84 92 <span type="species:ncbi:9606">patients</span>
RNA editing and the death of motor neurons: there is a glutamate-receptor defect in patients with amyotrophic lateral sclerosis
###end article-title 28
###begin article-title 29
Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis
###end article-title 29
###begin article-title 30
Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes
###end article-title 30
###begin article-title 31
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Superoxide dismutase gene mutations in Italian patients with familial and sporadic amyotrophic lateral sclerosis: identification of three novel missense mutations
###end article-title 31
###begin article-title 32
Penco SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study
###end article-title 32
###begin article-title 33
A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis
###end article-title 33
###begin article-title 34
World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
###end article-title 34
###begin article-title 35
Website title
###end article-title 35

